Visit Sclero Forums, Chats and Blogs!
 
Search sclero.org:
 
The most important thing in the world to know about
scleroderma is sclero.org with 5,000+ pages in 23 languages!
 
Donate in MemoryIn loving memory of Tom Regensburger, and Vera Kortan . (Donate)
Home   Medical   News   *Sclero Forums*   Support   Languages/Countries
Earn $150 on July 30th in Boston Marketing Research Study if you have scleroderma or CTD and have been screened for pulmonary hypertension!
Frog jumping for joy by Shelley EnszPDF Flyer: Boston Marketing Research Study. Schlesinger Associates-Boston, a national marketing research company, is currently looking for patients who have been diagnosed with Scleroderma or other Connective Tissue Disease, who either have pulmonary hypertension or who are regularly screened for it, to participate in a July 30th paid marketing research study in Boston. Read PDF Flyer: Boston Marketing Research Study or call Katherine at 617-542-5500 x310. Schlesinger Associates-Boston. Posted 07/26/10.
 
LUNG (PULMONARY): MAIN MENU
Lung (Pulmonary) Overview
Aspiration Pneumonia
Oxygen Therapy
Pleural Effusion
Pulmonary Fibrosis
Pulmonary Hypertension
Preventive Care
Pulmonary Support Resources
Pulmonary Hypertension
What is PH?
Primary PH
Isolated PH
Secondary PH
Exercised Induced PH
Causes of PH

PH Disease Correlations
Symptoms
Diagnosis
Prognosis

Treatments
Research Registries
Research
Patient Support Organizations
Personal Stories

Treatments for Pulmonary Hypertension

Bosentan/Tracleer
Endothelin Receptors (Sitaxsentan/Ambrisentan)
Inhaled Prostacyclin (Ventavis, Iloprost)
Inhaled Nitric Oxide
Heart/Lung Transplants
Prostacyclin (Flolan, Epoprostenol) Warning
Sildenafil Citrate (Revatio, Viagra)
Stem Cell Transplant
Treprostinil (TYVASO)
Warfarin (Coumadin)

Treatments for Pulmonary Hypertension: Lung Transplants

Many centers do not approve heart or lung transplants for Scleroderma patients, however, a few of them do, so contact the Second Wind Lung Transplant Association for further information.
First Mouse Lung Transplants Lay Groundwork For New Ways To Prevent Transplant Rejection In Humans. Surgeons have developed the first mouse model of lung transplantation, and they're hoping it will help explain why the success of the procedure in humans lags far behind other solid organ transplants. Five years after lung transplant surgery, only about 45 percent of patients are still alive. ScienceDaily. Washington University School of Medicine. 07/13/07.
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis (IPF) and idiopathic pulmonary arterial hypertension (IPAH). Patients with scleroderma who are recipients of lung transplantation experience similar rates of survival 2 years after the procedure compared with those with IPF or IPAH. Lung transplantation may represent a viable therapeutic option to consider for patients with end-stage lung disease due to scleroderma. PubMed. Arthritis Rheum. 2006 Dec;54(12):3954-61. (Also see: Pulmonary Fibrosis)
Essential pulmonary arterial hypertension. The recent discovery of BMPR2, a dominant gene with weak penetrance, has opened up several interesting possibilities in this setting. Pathophysiological research has identified a fall in vasodilatory substances and an increase in vasoconstrictive mediators, opening the way to medical treatments that can postpone the need for lung transplantation. PubMed. Bull Acad Natl Med. 2005 Mar;189(3):523-33; discussion 533-4.
 
Go to Inhaled Prostacyclin
 
SCLERO.ORG is brought to you by the nonprofit International Scleroderma Network (ISN). The ISN is a full-service nonprofit scleroderma charitable foundation providing stellar research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension.
  1. Post a message in Sclero Forums
  2. Email: isn@sclero.org
  3. English Email Form
  4. Español Email Form
  5. Italiano Email Form
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
United States

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.

Toll Free Hotline in U.S.
Hours: 9am-3pm CST only.
Please leave a complete message, in English.
1-800-564-7099
Direct Line
1-952-583-5735
We are also known as the Scleroderma from A to Z web site.
Privacy Policy, Financial Disclosure, and Disclaimer.
© Copyright 1998-2010 International Scleroderma Network
All Rights Reserved
 
Home   Donate   Medical   News   *Sclero Forums*   Support   Translations   Search